IP Library Granted Patent US 10,590,419
Granted Patent B2
US 10,590,419 · App. 15/311,765 · Granted Mar 17, 2020

MicroRNA induction of cardiac regeneration

Inventor: Edward E. Morrisey (Newtown Square, PA)
Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
C12N15/1137A61K31/19A61K31/7105A61K48/0058A61K48/0075C12N5/0657C12N5/0662C12N15/113C12N15/86A01K2227/105A01K2267/0375C12N2310/141C12N2320/32C12N2320/35C12N2501/65C12N2510/00C12N2740/15043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,590,419
App. No.
15/311,765
Granted
Mar 17, 2020
Kind
B2
Abstract

The invention relates to compostions and methods for promoting cellular proliferation and de-differentiation of cells into stem cells to foster tissue regeneration. Specifically, the invention relates to transiently administering a microRNA (miR) or its mimic for promoting cardiomyocyte proliferation and cardiac regeneration.

Claims (13)

1. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering locally to the heart of said subject a composition comprising a microRNA (miR) 302-367 cluster or a miR 302-367 cluster mimic, wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes.

2. The method of claim 1 , wherein the transient administration comprises a single administration of the composition to the subject.

3. The method of claim 1 , wherein the composition comprises valproic acid.

4. The method of claim 1 , wherein said miR is operably linked to a regulatory sequence.

5. The method of claim 4 , wherein said regulatory sequence is an inducible promoter.

6. The method of claim 5 , wherein said inducible promoter is a doxycycline inducible promoter.

7. The method of claim 1 , wherein said miR is encoded by a nucleic acid sequence present within a vector.

8. The method of claim 7 , wherein the vector is a viral vector.

9. The method of claim 8 , wherein the viral vector is a lentivirus vector.

10. The method of claim 7 , wherein the vector is a plasmid vector.

11. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering locally to the heart of said subject a composition comprising a microRNA (miR) cluster or its mimic, wherein said cluster comprises one or more of miR302b and miR302c or two or more of miR302b, miR302c, and miR367, and wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes.

12. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering intravenously at least once daily for 7 days said subject a composition comprising a microRNA (miR) 302-367 cluster or a miR 302-367 cluster mimic, wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes.

13. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering intravenously at least once daily for 7 days said subject a composition comprising a microRNA (miR) cluster or its mimic, wherein said cluster comprises one or more of miR302b and miR302c or two or more of miR302b, miR302c, and miR367, and wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2019
From: MORRISEY, EDWARD E
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 050981/0759 →
CONFIRMATORY LICENSE Recorded Apr 14, 2017
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042257/0037 →
Continuity (2)
Provisional Application 61994250 · May 16, 2014
Related Publication 20170096671A1 · Apr 6, 2017